Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07383246
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
NCT07138716
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06520319
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
Enrolling by Invitation
Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma
NCT07713901
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- IQVIA Parsippany, New Jersey, United States
Enrolling by Invitation
PET-TC in Thyroid Evaluation
NCT06852144
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
- Locations
-
- Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna Bologna, Bo, Italy
Enrolling by Invitation
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
NCT01511393
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
- Locations
-
- United BioSource, LLC Morgantown, West Virginia, United States
Not Yet Recruiting
A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
NCT07621146
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
- Locations
-
- BC Cancer Vancouver Vancouver, British Columbia, Canada
Not Yet Recruiting
Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications
NCT06121271
- Conditions
- Adenocarcinoma, Bronchial and Thymic Neuroendocrine Tumour, Carcinoma, +13 more
- Locations
-
Not specified
NCT05534594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- University Medical Centre Groningen Groningen, Provincie Groningen, Netherlands
NCT06067594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
- Locations
-
- Hospital Universitario Austral Pilar, Buenos Aires, Argentina
NCT01730638
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +12 more
- Locations
-
- Angers Hospital Angers, France
- Nantes Hospital Nantes, France
- Institut de Cancérologie de l'ouest, René Gauducheau Saint-Herblain, France
NCT00514046
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC
NCT03246659
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Department of Nuclear Medicine, Innsbruck Medical University Innsbruck, Austria
- Department of Nuclear Medicine, University Hospital Freiburg Freiburg im Breisgau, Germany
- Erasmus University Rotterdam Rotterdam, Netherlands
- Department of Endocrinology, Jagiellonian University Medical College Krakow, Poland
NCT00880503
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma, +17 more
- Locations
-
- Childrens Hospital, Pittsburgh Pittsburgh, Pennsylvania, United States
NCT02586350
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
NCT01424878
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
Active, Not Recruiting
Spanish Study for Molecular Characterization of Thyroid Carcinoma
NCT04970134
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +11 more
- Locations
-
- Hospital Universitario Vall d'Hebron Barcelona, Spain
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital Universitario Durán i Reinals L'Hospitalet de Llobregat, Barcelona, Spain
- Fundació Althaia Manresa, Barcelona, Spain